SCHEMBL29786282

SCHEMBL29786282

COc1ccc(-c2c[nH]c(OC)n2)cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.47
MAPK1 P28482 1/20 0.46
MKNK1 Q9BUB5 1/20 0.45
MKNK2 Q9HBH9 1/20 0.45
TDO2 P48775 1/20 0.45
MAPT P10636 1/20 0.44
CYP2A6 P11509 2/20 0.44
PDGFRB P09619 1/20 0.43
PDGFRA P16234 1/20 0.43
PRKAG1 P54619 1/20 0.42
PRKAA1 Q13131 1/20 0.42
PRKAB1 Q9Y478 1/20 0.42
ERN1 O75460 3/20 0.42
HSD17B1 P14061 1/20 0.41
HSD17B2 P37059 1/20 0.41
LOXL2 Q9Y4K0 1/20 0.41
MAP3K11 Q16584 1/20 0.41
PIK3CD O00329 1/20 0.40
PIP5K1C O60331 1/20 0.40
PIK3CA P42336 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23123842 1.00 CYP19A1 (0.47) CYP19A1MAPK1MKNK1MKNK2TDO2
SCHEMBL23123915 0.88 CYP19A1 (0.43) CYP19A1MAPK1MKNK1MKNK2TDO2
SCHEMBL4865238 0.84 CYP19A1 (0.47) CYP19A1MAPK1MKNK1MKNK2TDO2
SCHEMBL4866869 0.77 MKNK1 (0.47) CYP19A1MAPK1MKNK1MKNK2TDO2
SCHEMBL23411188 0.76 MAPK1 (0.45) CYP19A1MAPK1MKNK1MKNK2TDO2
SCHEMBL28797380 0.75 SLC2A1 (0.40) TDO2MAPTPDGFRBPIK3CBPIK3CG
SCHEMBL23124167 0.74 PDGFRB (0.55) CYP19A1MAPK1CYP2A6PDGFRB
SCHEMBL31174412 0.74 CYP2A6 (0.68) CYP19A1MKNK1MKNK2TDO2CYP2A6
SCHEMBL3754419 0.74 CYP2A6 (0.68) CYP19A1MKNK1MKNK2TDO2CYP2A6
SCHEMBL7644646 0.74 PDGFRB (0.49) MAPK1TDO2MAPTPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114787135-A Substituted imidazole carboxamides and their use in the treatment of medical disorders 比亚尔R&D投资股份公司 2022-07-22 CN disclosed